Trump and Kennedy's Health Industry Agreements Lack Enforcement and Face Uncertain Future
Source Summary
Agreements announced by Trump and Kennedy covering drug pricing, synthetic food dye reduction, and insurance prior authorization restrictions have not been enforced. The deals were publicly promoted as policy victories, but their lasting impact remains unclear.
Why it matters
The lack of enforcement raises questions about whether these publicly announced health policy commitments will produce substantive regulatory or market changes.
What remains uncertain
It is unclear whether the agreements will result in lasting change or be enforced.
